Upstream Bio, Inc. presented data at the European Academy of Allergy & Clinical Immunology Congress highlighting the advantages of verekitug, a treatment targeting the TSLP receptor, over tezepelumab, ...

Our models help scientists predict the results of new and currently impossible experiments to move their science forward much ...

The era of digital twins offers a future where deep biology, AI and real-world data combine to make medicine more personal, ...

Key market opportunities in the global cell biology research market include advances in instrumentation, consumables, and software driven by data-driven models. There's potential in enhanced ...

It has been pointed out that unless South Korea overcomes the challenge of securing accurate and extensive medical data, not only will the spread of ...

Discover how deep learning could refine biological age assessments to predict disease risk. Keep reading for clinical ...

In the rapidly evolving field of computational intelligence, there is a pressing demand for advanced tools and algorithms ...

CN Bio and Altis Biosystems, Inc. (“Altis”), leading developers of in vitro human organ models that optimize the accuracy and efficiency of drug development, today announced a strategic partnership.

SAN DIEGO, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Yatiri Bio Inc. today announced it has received a grant from the Gates ...